NewswireTODAY - /newswire/ - London, United Kingdom, 2008/10/28 - ReportBuyer.com, the online destination for business intelligence for major industry sectors, added a new report which provides a competitor analysis in the development pipeline of biosimilar versions of human Growth Hormone.

Report Buyer, has added a new report which provides a competitor analysis in the development pipeline of biosimilar versions of human Growth Hormone.

‘Human Growth Hormone (hGH)’ analyses the pipeline of biosimilar (biogeneric) versions of somatropin and next generation hGH products for treatment of growth hormone deficiency (GHD).

The report includes an evaluation of the hGH market size in 2007, based on published data and provides company pipelines in the field of hGH.

Human growth hormone was the first therapeutic protein for which a biosimilar version was approved in the U.S. and in Europe in 2006. Authors of the report say that Novartis' generic division Sandoz sells generic somatropin as Omnitrope at a 25 % discount but only achieved 2007 sales of about US$ 8 million representing a 0.3 % share of the worldwide hGH market in 2007 of US$ 2.7 billion.

The study says that although 2008 sales of Omnitrope are growing steadily, they can be expected to achieve only about US$ 30 million (about 1 % of the worldwide market).

Analysts say that the number of mere copycat hGH biosimilars in regulated markets is limited to a total of three approved versions in the EU and/or US and two other versions in the pipeline of 1st generation somatropin biogenerics.

The report says the majority of next generation products attempts to improve frequency of administration or delivery. Also engineering of hGH to prolong half-life is a next generation approach already in early clinical development, but still requires injection. In contrast, non-injectable delivery approaches promise to avoid injection by oral, transdermal or nasal administration.

There are numerous manufacturers of hGH in non-regulated markets, but most of them do not produce in a manner allowing approval in regulated markets although these products are frequently consumed by those interested in gaining muscle mass.

The report includes a compilation of current active projects in research and development of novel hGH products.

‘Human Growth Hormone (hGH)’ is available from Report Buyer. For more information, see website.

Report Buyer product ID: LME00016

About Report Buyer
Report Buyer is a UK-based independent online store supplying business information. The website now carries over 80,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

Agency / Source: Report Buyer Ltd

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick NewswireToday Visibility Checker

Distribution / Indexing: [+]